Johnson & Johnson, Risperdal maker hit with $8B verdict

October 08, 2019 - 4:56 pm

PHILADELPHIA (AP) — A Philadelphia jury has ruled that Johnson & Johnson and Janssen Pharmaceuticals must pay $8 billion in punitive damages over an antipsychotic drug linked to the abnormal growth of female breast tissue in boys.

A law firm for the plaintiff released a statement Tuesday saying the companies used an organized scheme to make billions of dollars while illegally marketing and promoting the drug called Risperdal.

Johnson & Johnson says the award "is grossly disproportionate with the initial compensatory award in this case," and that the company is "confident it will be overturned."